vs

Side-by-side financial comparison of Edwards Lifesciences (EW) and SS&C Technologies Holdings Inc (SSNC). Click either name above to swap in a different company.

Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $1.6B, roughly 1.0× SS&C Technologies Holdings Inc). Edwards Lifesciences runs the higher net margin — 23.1% vs 13.7%, a 9.4% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 8.8%). Over the past eight quarters, Edwards Lifesciences's revenue compounded faster (9.7% CAGR vs 6.5%).

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

SS&C Technologies Holdings, Inc. is an American multinational holding company headquartered in Windsor, Connecticut, that sells software and software as a service to the financial services industry. The company has offices in the Americas, Europe, Asia, Africa and Australia.

EW vs SSNC — Head-to-Head

Bigger by revenue
EW
EW
1.0× larger
EW
$1.6B
$1.6B
SSNC
Growing faster (revenue YoY)
EW
EW
+7.9% gap
EW
16.7%
8.8%
SSNC
Higher net margin
EW
EW
9.4% more per $
EW
23.1%
13.7%
SSNC
Faster 2-yr revenue CAGR
EW
EW
Annualised
EW
9.7%
6.5%
SSNC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EW
EW
SSNC
SSNC
Revenue
$1.6B
$1.6B
Net Profit
$380.7M
$226.1M
Gross Margin
78.0%
48.7%
Operating Margin
1.8%
24.2%
Net Margin
23.1%
13.7%
Revenue YoY
16.7%
8.8%
Net Profit YoY
6.8%
6.2%
EPS (diluted)
$0.66
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EW
EW
SSNC
SSNC
Q1 26
$1.6B
$1.6B
Q4 25
$1.6B
$1.7B
Q3 25
$1.6B
$1.6B
Q2 25
$1.5B
$1.5B
Q1 25
$1.4B
$1.5B
Q4 24
$1.4B
$1.5B
Q3 24
$1.4B
$1.5B
Q2 24
$1.4B
$1.5B
Net Profit
EW
EW
SSNC
SSNC
Q1 26
$380.7M
$226.1M
Q4 25
$91.2M
$193.1M
Q3 25
$291.1M
$210.0M
Q2 25
$333.2M
$180.8M
Q1 25
$358.0M
$213.0M
Q4 24
$385.6M
$248.2M
Q3 24
$3.1B
$164.4M
Q2 24
$366.3M
$190.3M
Gross Margin
EW
EW
SSNC
SSNC
Q1 26
78.0%
48.7%
Q4 25
78.1%
47.8%
Q3 25
77.8%
47.7%
Q2 25
77.5%
48.0%
Q1 25
78.7%
49.3%
Q4 24
78.9%
49.3%
Q3 24
80.6%
48.0%
Q2 24
79.9%
48.1%
Operating Margin
EW
EW
SSNC
SSNC
Q1 26
1.8%
24.2%
Q4 25
9.6%
22.3%
Q3 25
19.8%
23.3%
Q2 25
26.8%
22.4%
Q1 25
27.9%
23.6%
Q4 24
22.6%
23.4%
Q3 24
25.9%
22.2%
Q2 24
26.8%
22.6%
Net Margin
EW
EW
SSNC
SSNC
Q1 26
23.1%
13.7%
Q4 25
5.8%
11.7%
Q3 25
18.7%
13.4%
Q2 25
21.7%
11.8%
Q1 25
25.3%
14.1%
Q4 24
27.8%
16.2%
Q3 24
226.7%
11.2%
Q2 24
26.7%
13.1%
EPS (diluted)
EW
EW
SSNC
SSNC
Q1 26
$0.66
$0.91
Q4 25
$0.16
$0.76
Q3 25
$0.50
$0.83
Q2 25
$0.56
$0.72
Q1 25
$0.61
$0.84
Q4 24
$0.65
$0.98
Q3 24
$5.13
$0.65
Q2 24
$0.61
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EW
EW
SSNC
SSNC
Cash + ST InvestmentsLiquidity on hand
$420.9M
Total DebtLower is stronger
$7.4B
Stockholders' EquityBook value
$6.9B
Total Assets
$20.3B
Debt / EquityLower = less leverage
1.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EW
EW
SSNC
SSNC
Q1 26
$420.9M
Q4 25
$4.2B
$462.1M
Q3 25
$3.8B
$388.3M
Q2 25
$4.1B
$480.3M
Q1 25
$3.9B
$515.0M
Q4 24
$4.0B
$567.1M
Q3 24
$4.4B
$694.7M
Q2 24
$2.0B
$462.7M
Total Debt
EW
EW
SSNC
SSNC
Q1 26
$7.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
EW
EW
SSNC
SSNC
Q1 26
$6.9B
Q4 25
$10.3B
$6.9B
Q3 25
$10.2B
$6.9B
Q2 25
$10.5B
$6.9B
Q1 25
$10.1B
$6.8B
Q4 24
$10.0B
$6.5B
Q3 24
$9.5B
$6.8B
Q2 24
$7.4B
$6.4B
Total Assets
EW
EW
SSNC
SSNC
Q1 26
$20.3B
Q4 25
$13.7B
$20.7B
Q3 25
$13.3B
$19.5B
Q2 25
$13.5B
$19.0B
Q1 25
$13.0B
$20.4B
Q4 24
$13.1B
$19.0B
Q3 24
$13.0B
$18.4B
Q2 24
$10.1B
$16.9B
Debt / Equity
EW
EW
SSNC
SSNC
Q1 26
1.08×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EW
EW
SSNC
SSNC
Operating Cash FlowLast quarter
$299.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.33×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EW
EW
SSNC
SSNC
Q1 26
$299.7M
Q4 25
$450.9M
$643.5M
Q3 25
$573.7M
$456.2M
Q2 25
$290.2M
$372.9M
Q1 25
$280.4M
$272.2M
Q4 24
$-127.5M
$486.6M
Q3 24
$351.8M
$336.6M
Q2 24
$371.5M
$384.9M
Free Cash Flow
EW
EW
SSNC
SSNC
Q1 26
Q4 25
$353.5M
$633.0M
Q3 25
$516.2M
$421.5M
Q2 25
$240.9M
$350.0M
Q1 25
$224.4M
$259.5M
Q4 24
$-177.3M
$466.9M
Q3 24
$299.9M
$310.7M
Q2 24
$286.1M
$374.9M
FCF Margin
EW
EW
SSNC
SSNC
Q1 26
Q4 25
22.5%
38.3%
Q3 25
33.2%
26.9%
Q2 25
15.7%
22.8%
Q1 25
15.9%
17.1%
Q4 24
-12.8%
30.5%
Q3 24
22.1%
21.2%
Q2 24
20.9%
25.8%
Capex Intensity
EW
EW
SSNC
SSNC
Q1 26
0.0%
Q4 25
6.2%
0.6%
Q3 25
3.7%
2.2%
Q2 25
3.2%
1.5%
Q1 25
4.0%
0.8%
Q4 24
3.6%
1.3%
Q3 24
3.8%
1.8%
Q2 24
6.2%
0.7%
Cash Conversion
EW
EW
SSNC
SSNC
Q1 26
1.33×
Q4 25
4.94×
3.33×
Q3 25
1.97×
2.17×
Q2 25
0.87×
2.06×
Q1 25
0.78×
1.28×
Q4 24
-0.33×
1.96×
Q3 24
0.11×
2.05×
Q2 24
1.01×
2.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EW
EW

Segment breakdown not available.

SSNC
SSNC

Technology-enabled services$1.4B85%
License, maintenance and related$239.8M15%

Related Comparisons